AI pharmaceutical company Generate Biomedicines (GENB.US) sets IPO price at $16 per share, to be listed on Nasdaq tonight
Show original
This biotechnology company, currently in Phase III clinical trials, issued 25 million shares at $16 per share (the midpoint of the $15 to $17 price range), successfully raising $400 million.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
JPMorgan lowers Snowflake target price to $245
格隆汇•2026/02/27 09:02
Truist lowers Salesforce target price to $280
格隆汇•2026/02/27 08:55
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,924.79
-0.21%
Ethereum
ETH
$2,033.9
-1.06%
Tether USDt
USDT
$1
+0.01%
XRP
XRP
$1.42
-1.41%
BNB
BNB
$628.41
+0.12%
USDC
USDC
$1
+0.01%
Solana
SOL
$87.55
-0.03%
TRON
TRX
$0.2853
-0.34%
Dogecoin
DOGE
$0.09829
-1.47%
Cardano
ADA
$0.2919
-0.64%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now